Objective:To determine ex vivo antimalarial activity and cytotoxicity of endophytic Streptomyces SUK 08 as well as the main core structure fractionated from its crude extract.Methods:The activities of SUK 08 crude extract were evaluated by using the Plasmodium lactate dehydrogenase assay and synchronization test against rodent malaria parasite Plasmodium berghei,instead of human malarial parasite Plasmodium falciparum.The cytotoxicity of the crude extract was determined by MTT assay.The crude extract was analyzed by thin-layer chromatography and gas chromatography-mass spectrophotometry.Results:The ethyl acetate crude extract showed very promising antimalarial activity with IC50 of 1.25 mg/mL.The synchronization tests showed that ethyl acetate extraction could inhibit all stages of the Plasmodium life cycle,but it was most effective at the Plasmodium ring stage.On the basis of a MTT assay on Chang Liver cells,ethyl acetate and ethanol demonstrated IC50 values of ＞ 1.0 mg/mL.The IC50 of parasitemia at 5％ and 30％ for this extract was lower than chloroquine.Thin-layer chromatography,with 1∶9ratio of ethyl acetate:hexane,was used to isolate several distinct compounds.Based on gas chromatography-mass spectrophotometry analysis,three core structures were identiffed as cyclohexane,butyl propyl ester,and 2,3-heptanedione.Structurally,these compounds were similar to currently available antimalarial drugs.Conclusions:The results suggest that compounds isolated from Streptomyces SUK 08 are viable antimalarial drug candidates that require further investigations.

Objective To determine ex vivo antimalarial activity and cytotoxicity of endophytic Streptomyces SUK 08 as well as the main core structure fractionated from its crude extract. Methods The activities of SUK 08 crude extract were evaluated by using the Plasmodium lactate dehydrogenase assay and synchronization test against rodent malaria parasite Plasmodium berghei, instead of human malarial parasite Plasmodium falciparum. The cytotoxicity of the crude extract was determined by MTT assay. The crude extract was analyzed by thin-layer chromatography and gas chromatography–mass spectrophotometry. Results The ethyl acetate crude extract showed very promising antimalarial activity with IC

Chemical constituents and biological activities of the Mitrella kentii leaf oil were investigated in this study. Gas chromatography (GC) and gas chromatography-mass spectrometry (GC-MS) were used to determine the chemical constituents of the oil. The oil was evaluated for its ability to inhibit prostaglandin E2 (PGE2 ) and thromboxane B2 (TXB2 ) productions in human whole blood using a radioimmunoassay technique. Its inhibitory effect on plateletactivating factor (PAF) receptor binding with rabbit platelets using 3 H-PAF as a ligand and its free radical scavenging effect on DPPH were also investigated. Caryophyllene oxide (33.8%w/w), E,Z-farnesol (6.9%), benzyl benzoate (6.5%w/w) and viridiflorol (6.5%w/w) were among the major components of the oil. Even though weak inhibitory activities were observed in both PGE2 and TXB2 assays, significant results were obtained in both PAF receptor binding inhibition and 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging effect with IC50 value of 6.6 µg/mL and 155.6 µg/mL respectively. These promising activities warrant the development of the oil as an anti-inflammatory agent.